Clinical Liver Disease

Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus–infected patients with chronic kidney disease and end-stage renal disease

Informações:

Sinopse

Audible Article by Fernando Pedraza, Marco Ladino, David Roth